BNP Paribas Exane lifts target for Kimberly-Clark stock to USD 110.00

Published on 10/17/2026 at 21:15 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Results are due November 5, 2026 before the market opens. Kimberly-Clark stock costs USD 105.57 on October 16, 2026, up 1.44 percent on Nasdaq.

Analyst view and calendar

BNP Paribas Exane lifted its Kimberly-Clark target to USD 110.00 on October 16, 2026.
Kimberly-Clark is scheduled to release final third-quarter results on November 5, 2026.
Kimberly-Clark stock stood at USD 105.57 on October 16, 2026, up 1.44 percent versus the Nasdaq prior close.
Kimberly-Clark had a market capitalization of USD 35.1 billion and a P/E ratio of 17.95.

Moderne Papier- und Hygieneproduktion mit großen Papierrollen in einer Industriehalle — Kimberly-Clark (US4943681035) Papierfabrik zeigt riesige Papierrollen und moderne Produktionsanlagen in großer heller Industriehalle heute, Illustration mit AI erstellt.

BNP Paribas Exane raised its Kimberly-Clark target from USD 101.00 to USD 110.00 while maintaining a neutral rating in a report dated October 16, 2026, according to MarketBeat. The new target is 4.20 percent above the Nasdaq price of USD 105.57. Kimberly-Clark was last at USD 105.57 on Nasdaq on October 16, 2026 at 4:00 p.m. ET, up 1.44 percent versus the prior close of October 15, 2026.

November results set the next date

Kimberly-Clark is scheduled to release final third-quarter and nine-month results on November 5, 2026, with the release planned before the market opens and a management Q&A at 8:00 a.m. ET. The date was stated in the company's October 15 release, which also said its full-year 2026 outlook remained consistent with previous expectations, according to Kimberly-Clark.

Price position in the yearly range

The Nasdaq quote sat USD 13.48 above the 52-week low of USD 92.42 and USD 17.52 below the 52-week high of USD 123.09 on October 16, 2026. That places the stock 14.23 percent above its low and 14.24 percent below its high. Trading volume reached 4,353,649 shares against an average of 4,048,235 shares.

The company had a market capitalization of USD 35.1 billion, a P/E ratio of 17.95 and a 52-week range of USD 92.42 to USD 123.09 on October 16, 2026. BNP Paribas Exane's USD 110.00 target remains 4.20 percent above the Nasdaq price, while the firm's neutral rating sets a measured tone around the valuation.

Comparison with peers

Kimberly-Clark: plus 1.44 percent, P/E 17.95, market capitalization USD 35.1 billion
Clorox (NYSE, USD): plus 1.03 percent, P/E 18.11, market capitalization USD 10.5 billion
Procter & Gamble (NYSE, USD): plus 1.42 percent, P/E 24.06, market capitalization USD 370.0 billion

What the next report may clarify

The November 5 release will provide the next dated test of Kimberly-Clark's outlook and operating performance. Until then, the target revision, the Nasdaq price and the comparison with household-products peers define the stock's current market picture.

Kimberly-Clark stock was last at USD 105.57 on Nasdaq on October 16, 2026 at 4:00 p.m. ET, up 1.44 percent versus the prior close of October 15, 2026.